Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged sword

被引:0
|
作者
Azizi, Michel [1 ,2 ,3 ]
Monge, Matthieu [3 ]
Lorthioir, Aurelien [1 ,2 ]
Bobrie, Guillaume [1 ]
Amar, Laurence [1 ,2 ]
机构
[1] Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, F-75015 Paris, France
[2] Univ Paris 05, Paris, France
[3] Clin Investigat Ctr 9201, INSERM, Paris, France
关键词
BAROREFLEX ACTIVATION THERAPY; SELECTIVE ALDOSTERONE BLOCKER; BLOOD-PRESSURE; DOUBLE-BLIND; END-POINTS; SPIRONOLACTONE; EPLERENONE; TRIAL; ASSOCIATION; DENERVATION;
D O I
10.1097/HJH.0b013e328364bcdf
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:1948 / 1951
页数:4
相关论文
共 14 条
  • [1] Can We Study Hypertension in Patients on Dialysis? Yes We Can
    Georgianos, Panagiotis I.
    Agarwal, Rajiv
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (01) : 4 - 6
  • [2] Radiation With Immunotherapy May Be a Double-Edged Sword-How Can We Learn From Recent Negative Clinical Trials?
    Mcgee, Heather M.
    Williams, Terence M.
    Lee, Percy
    JAMA ONCOLOGY, 2024, 10 (08) : 1019 - 1020
  • [3] Alcohol Consumption Can be a "Double-Edged Sword" for Chronic Kidney Disease Patients
    Fan, Zhenliang
    Yun, Lie
    Yu, Shanshan
    Yang, Qiaorui
    Song, Liqun
    MEDICAL SCIENCE MONITOR, 2019, 25 : 7059 - 7072
  • [4] Etomidate for critically ill patients. Pro: yes we can use it
    Ray, David C.
    McKeown, Dermot W.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2012, 29 (11) : 506 - 510
  • [5] ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?
    Ruilope, LM
    Segura, J
    Schiffrin, EL
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2003, 4 (02) : 74 - 79
  • [6] Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!
    Lemaitre, Florian
    CLINICAL PHARMACOKINETICS, 2022, 61 (08) : 1071 - 1073
  • [7] Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!
    Florian Lemaitre
    Clinical Pharmacokinetics, 2022, 61 : 1071 - 1073
  • [8] USE OF SILDENAFIL IN PATIENTS WITH SEVERE SYSTOLIC DYSFUNCTION AND PULMONARY HYPERTENSION: CAN WE DO BETTER?
    Leblanc, M.
    Bernier, M.
    Nalli, C.
    Bergeron, S.
    Bourgault, C.
    Cantin, B.
    Proulx, G.
    Senechal, M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 91D - 91D
  • [9] Can patients with alcohol use disorders return to social drinking? Yes, so what should we do about it?
    Hodgins, D
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (05): : 264 - 265
  • [10] THE USE OF BIOMARKERS IN THE DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER: CAN WE PREDICT THE PATIENTS WHO WILL BE RESISTANT TO TREATMENT?
    Alkis, O.
    Zumrutbas, A. E.
    Toktas, C.
    Aybek, H.
    Aybek, Z.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S359 - S360